Weiss Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Weiss Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Buy	+4,677	New	+$2.07M	0.02%	318
2021 Q3	–	Sell	-9,428	Closed	-$1.9M	–	614
2021 Q2	$1.9M	Buy	+9,428	New	+$1.97M	0.05%	310
2018 Q4	–	Sell	-3,808	Closed	-$734K	–	491
2018 Q3	$734K	Hold	3,808	–	–	0.06%	110
2018 Q2	$647K	Hold	3,808	–	–	0.06%	108
2018 Q1	$621K	Hold	3,808	–	–	0.05%	108
2017 Q4	$571K	Buy	3,808 +2,145	+129%	+$318K	0.05%	111
2017 Q3	$253K	Buy	+1,663	New	+$250K	0.03%	86

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Weiss Asset Management's VRTX Position: Q2 2026 in Review

Weiss Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 4,677 shares worth $2.32M. The stake represents 0.02% of the portfolio and ranks #318 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in VRTX as recently as Q2 2021.

Weiss Asset Management first reported a position in VRTX in Q3 2017 and has held it in 7 quarters since. 1,763 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Weiss Asset Management held 4,677 shares of Vertex Pharmaceuticals worth $2.32M as of Q2 2026.
Vertex Pharmaceuticals was a new Weiss Asset Management position in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of Weiss Asset Management's portfolio in Q2 2026, its #318 holding.
Weiss Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 7 quarters since.
1,763 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.